Joel Greenblatt's TWST Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 3,169 shares of Twist Bioscience Corporation (TWST) worth $326,027, representing 0.00% of the portfolio. First purchased in 2023-Q2, this medium-term investment has been held for 9 quarters.
Based on 13F filings, Joel Greenblatt has maintained a strategic position in TWST, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2023, adding 30,537 shares. Largest reduction occurred in Q3 2024, reducing 51,314 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Twist Bioscience Corporation (TWST) Holding Value Over Time
Track share changes against reported price movement
Quarterly Twist Bioscience Corporation (TWST) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +3,169 | New Buy | 3,169 | $102.88 |
| Q1 2025 | -16,925 | Sold Out | 0 | $0.00 |
| Q4 2024 | -10,813 | Reduce 38.98% | 16,925 | $46.47 |
| Q3 2024 | -51,314 | Reduce 64.91% | 27,738 | $45.18 |
| Q2 2024 | +18,180 | Add 29.87% | 79,052 | $49.28 |
| Q1 2024 | +5,793 | Add 10.52% | 60,872 | $34.31 |
| Q4 2023 | +12,481 | Add 29.30% | 55,079 | $36.86 |
| Q3 2023 | +30,537 | Add 253.19% | 42,598 | $20.26 |
| Q2 2023 | +12,061 | New Buy | 12,061 | $20.46 |
Joel Greenblatt's Twist Bioscience Corporation Investment FAQs
Joel Greenblatt first purchased Twist Bioscience Corporation (TWST) in Q2 2023, acquiring 12,061 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Twist Bioscience Corporation (TWST) for 9 quarters since Q2 2023.
Joel Greenblatt's largest addition to Twist Bioscience Corporation (TWST) was in Q3 2023, adding 42,598 shares worth $863,035.
According to the latest 13F filing for Q2 2026, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 3,169 shares of Twist Bioscience Corporation (TWST), valued at approximately $326,027.
As of the Q2 2026 filing, Twist Bioscience Corporation (TWST) represents approximately 0.00% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Twist Bioscience Corporation (TWST) was 79,052 shares, as reported at the end of Q2 2024.